About University of Pittsburgh CRS
Clinical Trials at University of Pittsburgh CRS
During the past decade, University of Pittsburgh CRS conducted 21 clinical trials. In the 10-year time frame, 21 clinical trials started and 13 clinical trials were completed, i.e. on
average, 61.9% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 7 clinical trials were completed. i.e. 70%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "University of Pittsburgh CRS"
#1 collaborator was "AIDS Clinical Trials Group" with 6 trials as a collaborator, "Dynavax Technologies Corporation" with 2 trials as a collaborator, "CONRAD" with 1 trials as a collaborator, "Fred Hutchinson Cancer Center" with 1 trials as a collaborator and "Gilead Sciences" with 1 trials as a collaborator. Other collaborators include 9 different institutions and companies that were
collaborators in the rest 19 trials.
Clinical Trials Conditions at University of Pittsburgh CRS
According to Clinical.Site data, the most researched conditions in "University of Pittsburgh CRS" are
"HIV Infections" (28 trials), "Hepatitis C" (3 trials), "HIV Infection" (2 trials), "CMV" (1 trials) and "COVID-19" (1 trials). Many other conditions were trialed in "University of Pittsburgh CRS" in a lesser frequency.
Clinical Trials Intervention Types at University of Pittsburgh CRS
Most popular intervention types in "University of Pittsburgh CRS" are "Drug" (23 trials), "Biological" (10 trials), "Other" (3 trials), "Device" (1 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (10 trials), "Dapivirine gel" (2 trials), "Maraviroc" (2 trials), "Placebo IVR" (2 trials) and "Placebo gel" (2 trials). Other intervention names were less common.
Clinical Trials Genders at University of Pittsburgh CRS
The vast majority of trials in "University of Pittsburgh CRS" are
29 trials for "All" genders and 4 trials for "Female" genders.
Clinical Trials Status at University of Pittsburgh CRS
Currently, there are NaN active trials in "University of Pittsburgh CRS".
undefined are not yet recruiting,
5 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 23 completed trials in University of Pittsburgh CRS,
1 suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in University of Pittsburgh CRS, 14 "Phase 1"
clinical trials were conducted, 12 "Phase 2" clinical
trials and 7 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 2 trials that are defined as “Not Applicable".